About Palette Life Sciences
Palette Life Sciences is a Healthcare company based in Stockholm (Sweden) founded in 2016, and was acquired by Teleflex Medical in July 2023. Generic finished formulations are manufactured for urology and colorectal conditions. Palette Life Sciences has raised $30 million across 3 funding rounds from investors including SVB, Teleflex Medical and Orbimed. Palette Life Sciences offers products and services including Barrigel and Deflux. Its focus areas include Traditional Pharmaceuticals, Generics, Injectables and Traditional Medical Devices. Its legal entity is Palette Life Sciences, Inc.
Company details
Palette Life Sciences was founded in 2016 and is based in Stockholm, Sweden. Operations center on the production of generic finished formulations within the pharmaceutical sector. Key products include Deflux for vesicoureteral reflux, Solesta for fecal incontinence, Barrigel for rectal wall protection during radiotherapy, and Lidbree. Focus areas encompass urology, urogynecology disorders, colorectal conditions, and interventional oncology procedures.
- Headquarters Stockholm, Sweden
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website palettelifesciences.com
- Social LinkedIn
- Acquired by Teleflex Medical (Jul 2023)
- Legal Name Palette Life Sciences, Inc
- Total Equity Funding$30M (USD)
in 3 rounds
- InvestorsSVB
& 3 more
- Acquired byTeleflex Medical
(Jul 2023)
Products & Services of Palette Life Sciences
Palette Life Sciences offers a comprehensive portfolio of products and services, including Barrigel and Deflux.
Barrigel is utilized in medical applications as a trademark that was acquired by Teleflex
Deflux is employed in urological treatments and is recognized as a trademark under Teleflex
Funding Insights of Palette Life Sciences
Palette Life Sciences has successfully raised a total of $30M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 3
- First Round $30M
(Oct 2021)
- Investors Count 3
All 3 funding rounds of Palette Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Palette Life Sciences
Palette Life Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Teleflex Medical and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Business consulting services are provided by Schörling in Sweden. | 2018 | schorlingab.se | Stockholm, Sweden | |
Provider of medical devices for emergency medicine and various health conditions | 1943 | teleflex.com | Wayne, United States |
Investor details for Palette Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Palette Life Sciences
14 people are tracked at Palette Life Sciences (4 in leadership, 6 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Per Langoe | CEO | Leadership |
Ole Steven Mikkelsen | Chief Operating Officer | Leadership |
Richard Low Jr. | VP of Marketing | Leadership |
Cliff Kline | Director Of Clinical Affairs | Leadership |
Gun Nilsson | Director | Board & advisors |
Paul De Potocki | Director | Board & advisors |
David R. Amerson | Chairman | Board & advisors |
Newton Aguiar | Director | Board & advisors |
Mattias Klintemar | Director | Board & advisors |
Samuel E. Navarro | Director | Board & advisors |
Domenique Severo | Barrigel Procedural Specialist, Northeast | Team |
Jon Starke | Barrigel Procedural Specialist-central Region | Team |
Jacqueline Gehrke | Procedural Specialist- Barrigel | Team |
Mary McEwen | Corporate Manager | Team |
Complete people profiles for Palette Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Palette Life Sciences
4 dated milestones of Palette Life Sciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Palette Life Sciences is founded.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Debt – Conventional,.
- Exit Acquired by Teleflex Medical.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Palette Life Sciences
Palette Life Sciences was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Palette Life Sciences is headquartered in Stockholm, Sweden.
Palette Life Sciences is a funded company, having raised a total of $30M across 3 funding rounds to date. The company's 1st funding round was a Series B of $30M, raised on Oct 2021.
Palette Life Sciences was founded in 2016 and is based in Stockholm, Sweden. Operations center on the production of generic finished formulations within the pharmaceutical sector. Key products include Deflux for vesicoureteral reflux, Solesta for fecal incontinence, Barrigel for rectal wall protection during radiotherapy, and Lidbree. Focus areas encompass urology, urogynecology disorders, colorectal conditions, and interventional oncology procedures.
Palette Life Sciences offers Barrigel and Deflux.
Palette Life Sciences has 4 investors. Key investors include SVB, Teleflex Medical, Orbimed, and Schörling.
Palette Life Sciences operates through Palette Life Sciences, Inc.
Yes. Palette Life Sciences was acquired by Teleflex Medical in July 2023.